NCT04609761View on ClinicalTrials.gov

Open-label Trial of IVIG in Children With PANS

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
PANS Pediatric Acute-Onset Neuropsychiatric Syndrome
Interventions
DRUG

Privigen Injectable Product (Intravenous Immunoglobulin)

Privigen, 2 g/kg BW every 4th week for 6 months (= 6 infusions).

Trial Locations (1)

411 19

RECRUITING

Gillberg Neuropsychiatry Centre, Gothenburg

All Listed Sponsors
lead

Göteborg University

OTHER